BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9177962)

  • 1. Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group.
    Troke PF
    Eur J Clin Microbiol Infect Dis; 1997 Apr; 16(4):287-95. PubMed ID: 9177962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents.
    Robinson PA; Knirsch AK; Joseph JA
    Rev Infect Dis; 1990; 12 Suppl 3():S349-63. PubMed ID: 2330489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical study of fluconazole for the treatment of deep mycoses.
    Ikemoto H
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):239S-247S. PubMed ID: 2556241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole orally dispersible tablets for the treatment of patients with oropharyngeal candidiasis.
    Vandercam B; Gibbs D; Valtonen M; Jäger H; Armignacco O
    J Int Med Res; 1998; 26(4):209-18. PubMed ID: 9818788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole monotherapy for cryptococcosis in non-AIDS patients.
    Yamaguchi H; Ikemoto H; Watanabe K; Ito A; Hara K; Kohno S
    Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):787-92. PubMed ID: 8950555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluconazole: a new triazole antifungal agent.
    Morrow JD
    Am J Med Sci; 1991 Aug; 302(2):129-32. PubMed ID: 1897559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
    Stern JJ; Hartman BJ; Sharkey P; Rowland V; Squires KE; Murray HW; Graybill JR
    Am J Med; 1988 Oct; 85(4):477-80. PubMed ID: 2845778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan.
    Mikamo H; Matsumizu M; Nakazuru Y; Okayama A; Nagashima M
    J Infect Chemother; 2015 Jul; 21(7):520-6. PubMed ID: 25887336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS.
    Laine L; Rabeneck L
    Aliment Pharmacol Ther; 1995 Oct; 9(5):553-6. PubMed ID: 8580277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.
    Grant SM; Clissold SP
    Drugs; 1990 Jun; 39(6):877-916. PubMed ID: 2196167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole dose recommendation in urinary tract infection.
    Boedeker KS; Kilzer WJ
    Ann Pharmacother; 2001 Mar; 35(3):369-72. PubMed ID: 11261537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.
    Sugar AM; Saunders C
    Am J Med; 1988 Oct; 85(4):481-9. PubMed ID: 2845779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with fluconazole of severe fungal infections in immunocompromised patients].
    Boulos M
    Rev Inst Med Trop Sao Paulo; 1993; 35(1):81-7. PubMed ID: 8278747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole treatment of neonates and infants with severe fungal infections.
    Gürpinar AN; Balkan E; Kiliç N; Kiriştioğlu I; Avşar I; Doğruyol H
    J Int Med Res; 1997; 25(4):214-8. PubMed ID: 9283996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.
    De Wit S; Urbain D; Rahir F; Weerts D; Clumeck N
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):503-5. PubMed ID: 1915385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS.
    Vazquez JA; Zawawi AA
    HIV Clin Trials; 2002; 3(5):379-85. PubMed ID: 12407487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole.
    Med Lett Drugs Ther; 1990 May; 32(818):50-2. PubMed ID: 2185400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.